BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25613132)

  • 1. Improved Performance of COBAS AmpliPrep/COBAS TaqMan Version 2.0 Assay Over Amplicor Monitor Version 1.5 in the Quantification of HIV-1 RNA Viral Load in Abuja, Nigeria.
    Abubakar A; Ndembi N; Ogbanufe O; Inalegwu A; Wilson S; Ebagua I; Peters S; Chime C; Dakum P; Abimiku AG
    Curr HIV Res; 2015; 13(4):262-7. PubMed ID: 25613132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performance.
    Pyne MT; Brown KL; Hillyard DR
    J Clin Microbiol; 2010 Aug; 48(8):2852-8. PubMed ID: 20573864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 assays.
    Scott LE; Noble LD; Moloi J; Erasmus L; Venter WD; Stevens W
    J Clin Microbiol; 2009 Jul; 47(7):2209-17. PubMed ID: 19420172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays.
    Damond F; Roquebert B; Bénard A; Collin G; Miceli M; Yéni P; Brun-Vezinet F; Descamps D
    J Clin Microbiol; 2007 Oct; 45(10):3436-8. PubMed ID: 17715371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
    Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
    J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High correlation between the Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes.
    Karasi JC; Dziezuk F; Quennery L; Förster S; Reischl U; Colucci G; Schoener D; Seguin-Devaux C; Schmit JC
    J Clin Virol; 2011 Nov; 52(3):181-6. PubMed ID: 21813320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordance of HIV-1 RNA Values by Amplicor and TaqMan 2.0 in Patients With Confirmed Suppression in Clinical Trials.
    Garner W; White K; Szwarcberg J; McCallister S; Zhong L; Wulfsohn M
    Clin Infect Dis; 2016 Apr; 62(7):929-934. PubMed ID: 26689956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays.
    Sire JM; Vray M; Merzouk M; Plantier JC; Pavie J; Maylin S; Timsit J; Lascoux-Combe C; Molina JM; Simon F; Delaugerre C
    J Acquir Immune Defic Syndr; 2011 Mar; 56(3):239-43. PubMed ID: 21164353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test: comparison with the Cobas Amplicor HIV-1 Monitor test (manual specimen preparation).
    Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
    J Clin Virol; 2002 Dec; 25 Suppl 3():S103-7. PubMed ID: 12467784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA.
    Pas S; Rossen JW; Schoener D; Thamke D; Pettersson A; Babiel R; Schutten M
    J Clin Microbiol; 2010 Apr; 48(4):1195-200. PubMed ID: 20164281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fully automated quantification of human immunodeficiency virus (HIV) type 1 RNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan system.
    Schumacher W; Frick E; Kauselmann M; Maier-Hoyle V; van der Vliet R; Babiel R
    J Clin Virol; 2007 Apr; 38(4):304-12. PubMed ID: 17329164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of low-level plasma HIV viral load on COBAS TaqMan HIV-1 assays for patients with undetectable plasma viral load on COBAS Amplicor monitor version 1.5.
    Manavi K
    HIV Clin Trials; 2008; 9(4):283-6. PubMed ID: 18753122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification.
    Damond F; Avettand-Fenoel V; Collin G; Roquebert B; Plantier JC; Ganon A; Sizmann D; Babiel R; Glaubitz J; Chaix ML; Brun-Vezinet F; Descamps D; Rouzioux C
    J Clin Microbiol; 2010 Apr; 48(4):1413-6. PubMed ID: 20129964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the automated COBAS AmpliPrep/COBAS TaqMan HIV-1 test on a genetically diverse panel of specimens from China: comparison to the COBAS amplicor HIV-1 monitor test, v1.5.
    Xu S; Song A; Li X; Nie J; Zhang C; Wang Y
    Intervirology; 2010; 53(4):221-8. PubMed ID: 20332651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-level viremia associated with the use of TaqMan assay.
    Szabo S; Moffett LE; Cantwell-McNelis K; James CW; Joseph A
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(4):203-5. PubMed ID: 20530465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma load discrepancies between the Roche Cobas Amplicor human immunodeficiency virus type 1 (HIV-1) Monitor version 1.5 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 assays.
    Yao JD; Germer JJ; Damond F; Roquebert B; Descamps D
    J Clin Microbiol; 2008 Feb; 46(2):834; author reply 834. PubMed ID: 18252859
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of quantification of HIV-1 RNA viral load in plasma and dried blood spots by use of the semiautomated Cobas Amplicor assay and the fully automated Cobas Ampliprep/TaqMan assay, version 2.0, in Kisumu, Kenya.
    Ouma KN; Basavaraju SV; Okonji JA; Williamson J; Thomas TK; Mills LA; Nkengasong JN; Zeh C
    J Clin Microbiol; 2013 Apr; 51(4):1208-18. PubMed ID: 23390278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of underquantification of human immunodeficiency virus type 1 load with the second version of the Roche Cobas AmpliPrep/Cobas TaqMan assay.
    De Bel A; Marissens D; Debaisieux L; Liesnard C; Van den Wijngaert S; Lauwers S; Piérard D
    J Clin Microbiol; 2010 Apr; 48(4):1337-42. PubMed ID: 20164284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cobas ampliprep/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level.
    Taylor N; Grabmeier-Pfistershammer K; Egle A; Greil R; Rieger A; Ledergerber B; Oberkofler H
    PLoS One; 2013; 8(8):e74024. PubMed ID: 24023696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the QIAGEN artus HIV-1 QS-RGQ test with the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 test v2.0.
    Wall GR; Perinpanathan D; Clark DA
    J Clin Virol; 2012 Sep; 55(1):62-6. PubMed ID: 22739101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.